Dr. Endege has more than 20 Years’ experience in Academia-Biotech-Pharmaceutical industry in U.S at The Harvard Institute of Proteomics of Harvard University Medical School, Massachusetts General Hospital-Partners HealthCare, Chiron Diagnostics Inc., Millennium Pharmaceuticals Inc., and AstraZeneca Pharmaceuticals. His research in cancer biomarkers, therapeutic targets and drug discovery has resulted to 5 patents issued.